Yahoo
HKSE - Delayed Quote HKD

JW (Cayman) Therapeutics Co. Ltd (2126.HK)

2.220 -0.010 (-0.45%)
At close: October 30 at 3:59:07 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
288,660
283,653
158,218
173,856
145,702
Cost of Revenue
122,989
110,571
80,902
85,637
86,946
Gross Profit
165,671
173,082
77,316
88,219
58,756
Operating Expense
387,278
415,592
536,597
658,611
755,078
Operating Income
-221,607
-242,510
-459,281
-570,392
-696,322
Net Non Operating Interest Income Expense
3,575
9,521
16,211
21,611
9,748
Pretax Income
-335,386
-552,225
-590,624
-767,996
-846,135
Tax Provision
3,067
3,067
0
0
0
Net Income Common Stockholders
-338,453
-555,292
-590,624
-767,996
-846,135
Diluted NI Available to Com Stockholders
-338,453
-555,292
-590,624
-767,996
-846,135
Basic EPS
-0.82
-1.34
-1.43
-1.87
-2.06
Diluted EPS
-0.82
-1.34
-1.43
-1.87
-2.06
Basic Average Shares
416,269.500
415,787
413,634
411,530
410,093
Diluted Average Shares
416,269.500
415,787
413,634
411,530
410,093
Total Operating Income as Reported
--
--
--
-789,607
-855,883
Total Expenses
510,267
526,163
617,499
744,248
842,024
Net Income from Continuing & Discontinued Operation
-338,453
-555,292
-590,624
-767,996
-846,135
Normalized Income
-186,179
-288,566.500
-458,418
-585,859
-845,967
Interest Income
12,505
20,955
28,431
34,026
16,535
Interest Expense
8,930
11,434
12,220
12,415
6,787
Net Interest Income
3,575
9,521
16,211
21,611
9,748
EBIT
-326,456
-540,791
-578,404
-755,581
-839,348
EBITDA
-326,456
-458,915
-488,741
-655,747
-752,274
Reconciled Cost of Revenue
122,989
110,571
80,902
85,637
86,946
Reconciled Depreciation
--
81,876
89,663
99,834
87,074
Net Income from Continuing Operation Net Minority Interest
-338,453
-555,292
-590,624
-767,996
-846,135
Total Unusual Items Excluding Goodwill
-203,032
-355,634
-132,206
-182,137
-168
Total Unusual Items
-203,032
-355,634
-132,206
-182,137
-168
Normalized EBITDA
-123,424
-103,281
-356,535
-473,610
-752,106
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-50,758
-88,908.500
0
0
0
12/31/2022 - 11/3/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: